E
Cosmos Health Inc. COSM
$0.3698 $0.052216.44% NASDAQ
Recommendation
Prev Close
$0.3176
Volume
489,418
Avg Vol (90D)
351,932
Market Cap
$8.64M
Dividend & Yield
--
52-Week Range
$0.2801 - $1.58
P/E (TTM)
--
EPS (TTM)
-$1.13
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
Cosmos Health Reports Full-Year 2024 Results: Revenue Increases 2% to $54.43 Million While Operating Expenses Decline 24.2% to $19.86 Million
4/16/2025 - Globe Newswire
Cosmos Health Further Expands Facility Upgrades Program at Cana Laboratories and Signs 5-Year Contract Manufacturing Agreement with Pharmex for 1.5 Million Bottles of the Antiseptic Drug AMBITASOL 1L
4/9/2025 - Globe Newswire
Cosmos Health Launches Sky Premium Life in Albania through Partnership with Pharma Cell; Secures Initial $300,000 Order
4/8/2025 - Globe Newswire
Cosmos Health Inc. (NASDAQ:COSM) Might Not Be As Mispriced As It Looks After Plunging 31%
3/4/2025 - Simply Wall St
Cosmos Health Expands Sky Premium Life Nutraceuticals Brand with 60 New SKUs as Global Growth Accelerates
2/26/2025 - Accesswire
Insider Buying: Cosmos Health Inc. (NASDAQ:COSM) CEO Purchases 354,296 Shares of Stock
2/26/2025 - MarketBeat
Video: Tuesday 2/25 Insider Buying Report: COSM, SEPN
2/25/2025 - Market News Video
Cosmos Health Announces It will not Proceed with an Offering Under Its Form S-1
2/18/2025 - Accesswire
Cosmos Health Enters Final Development Phase of CCX0722 Weight Management Solution; Expected Product Launch in Q1 or Q2 2026, Gaining Access to Over $142 Billion Market
2/11/2025 - Accesswire
Cosmos Health Advances Cancer Treatment Innovation with Two New AI-Driven Patent Filings for Gliomas and Hematologic Malignancies; $25 Billion+ Global Market
2/10/2025 - Accesswire
Cosmos Health Strengthens Management Team with the Appointment of Veteran Executive Dimitris Moraitis as Vice President of Strategy & Operations
2/10/2025 - Accesswire
Cosmos Health Secures 10-Year Long-Term Contract Manufacturing Order from Provident Pharmaceuticals for 4 Additional Products, Totaling 8 Million Packs, Significantly Expanding High-Margin Revenue Backlog and Cash Flow Visibility
2/7/2025 - Accesswire
Cosmos Health Receives $578,460 Initial Purchase Order from Al Rabwa International for Sky Premium Life Food Supplements in Qatar
2/6/2025 - Accesswire
Cosmos Health Files New AI-Driven Patent Application for Multiple Sclerosis Treatment, Targeting $25 Billion+ Global Market
2/5/2025 - Accesswire
Cosmos Health Inc. (NASDAQ:COSM) CEO Grigorios Siokas Purchases 51,414 Shares
2/1/2025 - MarketBeat
Cosmos Health Secures Bond Loan from European Bank on Very Competitive Terms, with Option to Upsize to Support Growth and Achieve Positive Operating Cash Flow
1/28/2025 - Accesswire
Cosmos Health Submits Patent Application for Allergic Inflammation Therapy by Leveraging AI Drug Repurposing; Allergy Treatment Market Valued at $23.5 Billion
1/27/2025 - Accesswire
Cosmos Health Inc. (NASDAQ:COSM) CEO Buys $29,953.00 in Stock
1/24/2025 - MarketBeat
Cosmos Health Signs Expanded Exclusive Distribution Agreement with Virax Biolabs for Avian Influenza Virus PCR Kits in Saudi Arabia, the UAE, Qatar, and Kuwait
1/23/2025 - Accesswire
Cosmos Health Secures Two WIPO-Patented Anticancer Drugs for Prostate, Ovarian, and Colorectal Cancers, Valued at Over $24.5 Million
1/22/2025 - Accesswire
Cosmos Health CEO Greg Siokas Acquires a Total of 647,809 Shares Valued at $425,000 Over the Past 32 Days
1/21/2025 - Accesswire
Market Might Still Lack Some Conviction On Cosmos Health Inc. (NASDAQ:COSM) Even After 31% Share Price Boost
1/18/2025 - Simply Wall St
Cosmos Health Inc. (NASDAQ:COSM) CEO Purchases $50,000.00 in Stock
1/17/2025 - MarketBeat
Cosmos Health Inc. (NASDAQ:COSM) CEO Buys $99,836.26 in Stock
1/15/2025 - MarketBeat
Income Statement
Total Revenue (TTM)
$54.43M
EBITDA (TTM)
-$14.03M
EBIT (TTM)
-$15.25M
Net Income (TTM)
-$16.18M
Balance Sheet
Total Assets (Q)
$54.31M
Total Debt (Q)
$11.82M
Total Liabilities (Q)
$29.78M
Book Value Per Share (Q)
$1.04
Cash Flow
Cash from Operations (TTM)
-$7.72M
Cash from Investing (TTM)
-$798.10K
Cash from Financing (TTM)
$5.05M
Net Change in Cash (TTM)
-$3.52M
Filings
Filing Date
Tuesday, April 15, 2025
Period Date
Tuesday, December 31, 2024
Next Filing
Week of Aug 4 and 8 (est)
Price History
Loading...
Beta
1.79
7-Day Total Return
5.90%
30-Day Total Return
-21.57%
60-Day Total Return
-52.81%
90-Day Total Return
-50.97%
Year to Date Total Return
-46.09%
1-Year Total Return
-24.68%
2-Year Total Return
-88.76%
3-Year Total Return
-98.51%
5-Year Total Return
-99.31%
52-week Low
Apr 21, 2025 - $0.2801
52-week High
Aug 21, 2024 - $1.58
Valuation
Market Cap
$8.64M - Nano Cap
Enterprise Value
$20.12M
Price/Sales (TTM)
0.14
Price/Book (Q)
0.31
Dividends and Shares
Shares Outstanding
23.42M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.cosmosholdingsinc.com
Phone Number
312 536 3102
Address
5 Agiou Georgiou Str
Thessaloniki, 55438
Country
Greece
Year Founded
2009
Business Description
Sector
Health Care
Industry
Health Care Equipment and Services
Cosmos Health Inc. manufactures, develops, and trades branded nutraceutical products in Greece, the United States, Croatia, Bulgaria, Ireland, the Cayman Islands, the UAE, the United Kingdom, and... more
NASDAQ 04/22/2025 3:06PM Eastern Quotes delayed